Our articles
March 23, 2022
What’s new for the pharmaceutical industry in the 2021 ABPI Code update?
The Code of Practice for the Pharmaceutical Industry (the code) is published by the Association of the British Pharmaceutical Industry (ABPI) - find out what's new
Read now
November 25, 2020
One year at Enzyme Communications
Enzyme's company process revolves around four Ps (Position, Promise, Proof and Patient). After year one of working with us, Lois sums up her experience with her own four Ps
Read now
May 14, 2020
Are you using digital marketing to locate your clinical trial participants?
Figures from 2014 showed that up to 89% of pharmaceutical companies were failing to notice the potential of non-traditional methods of recruitment.[2] While this is no doubt changing, many companies have plenty of room to improve.
Read now
December 17, 2019
Tilt Brush – advanced applications for healthcare comms
Virtual reality (VR) has captivated the world of healthcare communications, creating enormous opportunity for pharmaceutical companies to bring their concepts to life. From mechanisms of action to disease awareness, the healthcare industry has been quick to adopt VR – but the opportunities are far from over.
Read now
January 7, 2019
New year, new approach?
Talking about science and selling scientific products and services to varied audiences is often not so different from traditional marketing.
Read now
January 4, 2019
What is science communication?
That’s a great question, and as science communication specialists, it’s a question that we ask ourselves a lot. To answer that question let’s begin with a boat full of sailors in 1747.
Read now
July 12, 2018
From Study to Story – harnessing the power of story telling
Do you have a newly published study that you want to communicate, or perhaps an existing study that you feel you could get more from? If so, Enzyme Communications ‘Study to Story’ process could be for you
Read nowGive us a call
+44 (0) 20 8058 8389
Drop us an email
Visit us
Cargoworks
1-2 Hatfields
London
SE1 9PG
